Cutiss

Zürich, Switzerland

Cutiss is a life science company that engages in regenerative medicine production, skin tissue engineering, and curated therapy solutions.

$38.9M raised

Sep 2025

Series C

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cutiss raised?

Cutiss has raised $38.9M in total funding. The most recent round was Series C. The last funding was announced in September 2025.

Who are Cutiss's investors?

Cutiss's investors include Zürcher Kantonal Bank, Innosuisse, Swisspreneur Syndicate, Shiloh Advisors, Government of France.

Where is Cutiss headquartered?

Cutiss is headquartered in Zürich, Switzerland.

What does Cutiss do?

Cutiss is a life science company that engages in regenerative medicine production, skin tissue engineering, and curated therapy solutions.

What stage is Cutiss at?

Cutiss is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 10, 2025.

MLA

"Cutiss — Funding & Investors." VCBacked, September 10, 2025, https://www.vcbacked.co/company/cutiss. Accessed July 9, 2026.

APA

VCBacked. (2025). Cutiss — Funding & Investors. Retrieved July 9, 2026, from https://www.vcbacked.co/company/cutiss

Wikipedia (cite web)

{{cite web |title=Cutiss — Funding & Investors |url=https://www.vcbacked.co/company/cutiss |website=VCBacked |access-date=July 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 10, 2025.